Poznámky k epizodě
This episode explored the long and strategic journey to achieving commercial coverage for ReActiv8 therapy, a restorative neurostimulation treatment for mechanical chronic low back pain. Our guests Mainstay Medical CEO, Jason Hannon discussed the origins of the therapy, the challenges of navigating the U.S. payer landscape, and the 15+ year investment in clinical research, culminating in the pivotal RESTORE trial. Dr. Kiran Patel offered insight into the RESTORE trial's compelling design, outcomes, and long-term durability, which played a critical role in convincing Anthem to become the…
Web: 826aac67-2880-4000-a609-09c6a90eb876.libsyn.com

